Methylphenidate in KBG Syndrome: N-of-1 Series — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Methylphenidate in KBG Syndrome: N-of-1 Series — Stella

Home/Kbg Syndrome/

View on ClinicalTrials.gov

Recruiting

Back to Kbg Syndrome trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Netherlands

Radboud University Medical Center, Nijmegen, Gelderland

Key details

Phase

Post-approval study

Sponsor

Radboud University Medical Center

Enrollment target

~15 participants

Started

November 2024

Primary completion

January 2027

Age range

6 Years – 20 Years

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.